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Treatment of failed native arteriovenous fistulae for hemodial- Since the initial description of the technique by Brescia
ysis by interventional radiology. et al in 1966 [1] native arteriovenous fistulae (AVF)
Background. We studied the feasibility, technical problems, remain the first choice hemodialysis access [2], but less
safety, and effectiveness of percutaneous declotting of throm-
attention has been paid to those that thrombose. Earlierbosed native arteriovenous fistulae for hemodialysis.
reports of surgical revision of thrombosed fistulae wereMethods. Between 1992 and 1998, 93 declotting procedures
so unimpressive that it was written in 1993 that “only awere performed in 73 consecutive upper limb native fistulae
(forearm 56 and upper arm 17), and 162 procedures were per- minority of thrombosed AVFs can be salvaged surgically
formed in 78 prosthetic grafts using manual catheter-directed following a thrombosis. For this reason, many surgeons
thromboaspiration, with or without previous urokinase infu- recommend that salvage procedures not be attempted onsion. Detection of restenosis by clinical surveillance led to
thrombosed AVF” [3], which was a way of encouragingredilation or stent placement. Rethromboses in four forearm
radiological alternatives.and six upper arm fistulae were treated by 20 further declottings
by aspiration. Although numerous techniques have been reported in
Results. The initial success was 93% in the forearm and 76% recent years for the percutaneous declotting of prosthetic
in the upper arm (99% in grafts). The complications included grafts in interventional radiology suites [4–16], only small
one pulmonary embolism, one acute pseudoaneurysm, and one series of fewer than 25 patients has been published con-blood depletion requiring transfusion. Primary patency rates
cerning thrombosed arteriovenous native fistulae [4, 7,at one year were 49% in the forearm and 9% in the upper
12, 13, 15, 17, 18]. There are several reasons for this: (1)arm (14% in grafts). Secondary patency rates were 81 and 50%
at one year, respectively (83% in grafts). Reinterventions were thrombosis of native fistulae is a far less frequent clinical
necessary every 19.6 months in the forearm and every 5.7 problem than for grafts [2]; (2) the problem of clotted
months in the upper arm (every 6.4 months in grafts, P , 0.05). native fistulae is even less frequent in the United States
Stents were placed in 11% of forearm fistulae and in 41% of
than in the rest of the world because grafts have beenupper arm fistulae (45% of grafts) for treatment of acute rup-
paradoxically predominant in the country of Brescia andture (5 out of 19), stenosis recoil (6 out of 19), and early (,6
Cimino, but this is likely to change if the recommenda-months) recurring stenosis (8 out of 19).
Conclusions. The percutaneous declotting of forearm fistu- tions of the National Kidney Foundation are enforced
lae by manual catheter-directed thromboaspiration was effec- [19]; and (3) percutaneous declotting techniques, which
tive in more than 90% of cases and yielded 50% primary and have recently been validated in grafts, are in general
80% secondary patency rates at one year. The results were
more difficult to perform in native fistulae.poorer in upper arm fistulae. The need for maintenance rein-
Although the technique for declotting a polytetra-terventions was three times smaller in forearm fistulae than in
fluoroethylene (PTFE) graft can easily be standardizedupper arm fistulae and grafts.
(a thick prosthetic wall that is easy to palpate and to
cannulate, a constant graft diameter, an average small
3.2 mL clot volume [20], an underlying stenosis locatedKey words: fistula, shunts, transluminal angioplasty, thrombectomy,
prostheses. at the venous anastomosis in the vast majority of cases),
thrombosed native fistulae result in a wider range ofReceived for publication July 13, 1999
difficulties: (1) The thin venous wall is difficult to palpateand in revised form September 7, 1999
Accepted for publication 1 December, 1999 and is transfixed without resistance. (2) The anatomy is
irregular, and it is frequently impossible to localize theÓ 2000 by the International Society of Nephrology
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anastomosis clinically. (3) The underlying stenosis can
occur anywhere from the feeding artery to the central
veins. (4) This underlying stenosis is frequently very tight
and difficult to traverse. (5) The collaterals are deceptive.
(6) A large volume of clots can be encountered. (7)
Aneurysms are more frequent than in grafts, with possi-
bly thick layers of old wall-adherent thrombi, and (8)
concomitant artery thrombosis is not rare, with sharp
arteriovenous angulation that may be impossible to tra-
verse from the fistula.
The aim of this study is to report the immediate and
long-term outcome after percutaneous declotting of 73
consecutive thrombosed native fistulae over a six-year
period, using the concept of direct manual aspiration of
the thrombus through a large lumen catheter with dila-
tion of underlying stenoses.
METHODS
Population
Between 1992 and 1998, a total of 93 percutaneous
declottings was performed in 73 consecutive native fistu-
lae in 29 women and 44 men: 64 declottings in 56 forearm
fistulae and 29 in 17 upper arm fistulae. Fifty-four fistulae
were radio-cephalic, 2 ulnar-basilic, 12 brachio-cephalic,
and 5 transposed brachio-basilic.
During the same period, 162 declottings were per-
formed using the same technique in 78 prosthetic grafts, Fig. 1. Principle of the placement of a safety guide wire. (A) Repeated
catheterization through stenoses, aneurysms, and angles of such a fistulaalthough these grafts accounted for only 20 to 30% of
is likely to be difficult, with risks of parietal damage. (B) After placementour arteriovenous access population.
of an introducer sheath, two different guide wires are carefully pushed
through the areas of concern. (C) The introducer sheath is then re-
Data collection moved, leaving the two guide wires in place. (D) The introducer sheath
is reintroduced over only one of the two guide wires, and the declottingAll data were collected prospectively. Success was de-
maneuvers are performed through it. The other guide wire becomes
fined as the possibility for the patient to undergo at the safety guide wire and is left in place during the whole procedure,
directly exiting from the skin beside the introducer.least one further dialysis treatment through the declotted
fistula. Follow-up was established by regular telephone
contacts with the nephrologists of the six referring hemo-
dialysis centers.
clinically located a few centimeters from the wrist anasto-
mosis, with no evidence of concomitant outflow stenosis,Contraindications
a single retrograde approach from the vein at the elbowThe only contraindications for percutaneous declotting
was sufficient to treat the whole fistula. On the otherwere infection and previously unused immature fistulae.
hand, when the first centimeters of the fistula were still
patent, a single antegrade approach from the patent seg-Basic principles
ment was sufficient.As for the treatment of any thrombosed dialysis access,
In typical cases, however, an initial (“venous”) 7F orthere were two stages: (1) removal of clots and (2) treat-
8F introducer sheath was usually placed under local anes-ment of the cause of the thrombosis, which in all cases
thesia a few centimeters from the anastomosis using anwas a tight underlying stenosis with a native fistula.
antegrade approach in order to treat the venous outflow.Percutaneous declotting was performed as an outpa-
A 5F catheter was then pushed over a guide wire up totient procedure. Anticoagulation (3000 units of heparin)
the superior vena cava and then slowly pulled back whileand antistaphylococcal antibiotics (0.75 g bolus intrave-
contrast medium was injected under fluoroscopy in ordernously of Cefamandolet; Lilly, St-Cloud, France) were
to localize the downstream (central) extension of thesystematically injected prior to clot removal.
thrombosis. The fistula was abandoned at this stage ifClinical examination was essential to choose the best
site for initial catheterization. When the stenosis was the venous outflow could not be traversed or recanalized.
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Fig. 2. (A) This thrombosed radiocephalic fistula of four months (large arrow 5 recent scar) was routinely used for hemodialysis. It was poorly
developed, and it was extremely difficult to palpate the vein. Only the recent hematomas at the dialysis cannulation sites were recognizable (thin
arrows). (B) To enter the lumen of the fistula, the solution was to place a tourniquet on the upper arm, which made the elbow vein swell and
became easily puncturable (arrow). (C) A 5F catheter was pushed down to the anastomosis. Prudent injection confirmed clots in a small diameter
and relatively immature vein, with filling of small collaterals. (D) Injection from the 5F catheter pushed into the feeding artery showed that clots
(arrow) really started from the anastomosis. (E) After predilation to 5 mm, which caused a small extravasation (star), clots were aspirated with
a 7F catheter (arrow) after placement of a safety guide-wire through the anastomosis (arrowheads). (F) Final result after aspiration and dilation
of the whole forearm vein to 6 mm. This fistula was used with no reintervention until the patient’s death four months later.
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Fig. 2. (Continued).
A second (“arterial”) introducer was then placed using clots in large, aneurysmal or curved vessels. The tip of
angled catheters can strip the vessel wall, and by (some-a retrograde approach some centimeters downstream
from the “venous” introducer in the direction of the times forceful) back and forth movement, it detaches
wall-adherent thrombi such as the arterial plug, the hardarterial inflow.
In order to obtain optimal prevention of pulmonary clot that frequently remains in contact with the blood
flow at the anastomosis. When more than 100 mL of bloodembolization of clots caused by reestablishment of arte-
rial flow, thrombi on the “venous” side were removed were aspirated (11 cases), additional aspirated blood was
immediately reinjected in the outflow after filtration.first, before the thrombi of the “arterial” side.
Clots were then aspirated according to the manual Once the thrombi were removed, the unmasked un-
derlying stenoses were dilated. High-pressure balloonscatheter-directed thromboaspiration method, which is
based on a simple concept [4, 13]: A slightly angled 7F (“Blue-Maxt;” Medi-Tech, Natick, MA, USA; or “Cen-
turiont;” Bard, Covington, GA, USA), which can beor 8F catheter with a firm wall, wide inner lumen and
soft tip (“Brite-Tipt”, multipurpose or vertebral curve; inflated up to 25 atmospheres, were used to abolish the
stenosis when necessary, with the aim of accepting abso-Cordis, Miami, FL, USA) is pushed through the intro-
ducer sheath, preferably over a guide wire, to make con- lutely no residual stenosis. The diameter of the balloon
was chosen to match the diameter of the immediatelytact with the thrombus. Strong manual aspiration is cre-
ated through a regular Luer-Lok 50 mL syringe while upstream or downstream normal vessel. However, dila-
tion before thromboaspiration was sometimes necessarypulling back the catheter. The syringe and the aspiration
catheter are flushed through a gauze into a cup, and to allow passage of the aspiration catheter to remove
clots immediately upstream or downstream from the ste-the procedure is repeated as long as clots remain. It is
essential to use angled catheters to be able to aspirate nosis.
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Fig. 2. (Continued).
The use of stents was limited to the treatment of acute immediately usable for dialysis. Systematic low molecu-
lar weight heparin was recommended for two weeks (En-ruptures not controlled by balloon tamponade, acute
pseudoaneurysms, and major stenosis recoil (.50%) oxaparinet; Rhoˆne-Poulenc-Rorer-Bellon, Montrouge,
France; 40 mg subcutaneously on nondialysis days), butafter dilation.
Three types of self-expandable stent were placed: the it was impossible to check whether all patients actually
received the treatment.Wallstentt, the Craggstentt and the Passagert (all 3
manufactured by Boston-Scientific Europe, La Garenne- From 1992 to 1994, we used an infusion technique de-
scribed in 1991 by Poulain et al: Two needles were placedColombes, France). The Wallstentt is a metallic stent
available in the United States. The Craggstentt is the in the thrombosed fistula in a crisscross fashion, and local
infusion of urokinase was performed at a dose of 50,000bare version of the Passagert, a nitinol stent covered
with Dacron, but neither is available in the United States. U/h in each needle for an average of two hours in the
recovery room [4]. When the angiography suite was avail-Finally, the whole fistula was checked from the feeding
artery to the superior vena cava in order to rule out able, needles were replaced by introducer sheaths. Resid-
ual thrombi were aspirated, and stenoses were dilated.residual thrombi and stenoses. Incidental arterial embo-
lism was sought and treated by thromboaspiration, even
Specific cases and technical subtletieswhen asymptomatic, with a 7F or 6F aspiration catheter
pushed over a hydrophilic guide wire on contact with The use of a “safety guide wire” is described in Figure 1.
Recent forearm fistulae, which were relatively imma-the embolus.
Final compression of the entry points of the introducers ture but nevertheless already used for dialysis, were fre-
quently impossible to palpate and to cannulate, espe-was significantly shortened by purse-string suturing,
which has been used since 1995 [21], and the fistula was cially when there were numerous stenoses with few clots.
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Fig. 3. (A) Radiocephalic fistula created only three months earlier but used routinely for dialysis for one month when it thrombosed. Access was
gained from the cephalic vein at the elbow. Careful manual contrast injection showed satisfactory anastomosis with a relatively immature small
diameter vein. (B) Despite the small 5 mm diameter used, dilation caused major rupture that was not controlled by three 10-minute periods of
low-pressure balloon tamponade. (C) The only solution to save the fistula was to place a covered stent (Passagert) across the rupture, giving this
excellent result despite the discrepancy in diameter between the 8 mm stent (smallest available diameter) and the 5 mm vein (arrows 5 extremities
of the stent). (D) This 10-month follow-up angiogram shows a perfect result, with no restenosis and no stent destruction, despite routine stent
cannulation for dialysis. This fistula was still working at 15 months of follow-up.
Figure 2 shows how to overcome this difficulty. The other problem common to native fistulae and grafts, but with
native fistulae, they share the technical problem of re-frequent problem with immature fistulae was the risk of
rupture of the vein (Fig. 3). moving huge clots without inducing significant pulmo-
nary embolism. Catheter-directed thromboaspirationWhen the anastomosis could not be reached using a
retrograde approach from the fistula, either because proved to be effective in thrombosed subclavian and
brachio-cephalic veins (Fig. 7).there was a stenosis or because the catheter and guide
wire were lost in collaterals, it was helpful to puncture
Follow-upthe brachial artery in order to opacify or to catheterize
the feeding artery, as shown in Figure 4. All patients were closely followed up in their dialysis
centers, with routine clinical examinations and surveil-Concomitant thrombosis of the feeding artery can also
necessitate an antegrade brachial approach, as described lance of dialysis parameters. Further angiography was
performed whenever there was suspicion of restenosis,in Figure 5.
Thrombi in aneurysms were not a problem when they with concomitant prophylactic redilation when confirmed.
Stents were placed in cases of severe angioplasty-inducedwere fresh. In contrast, old wall-adherent thrombi were
frequently resistant to aspiration, as described in rupture, soft residual stenosis (.30%) after redilation,
and early recurring (,6 months) stenosis. RethrombosisFigure 6.
Concomitant acute thrombosis of central veins is a was treated with further percutaneous thromboaspiration.
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Fig. 3. (Continued).
Statistical analysis 1998) was considered to be the (underestimated) interval
between interventions.The results are reported according to the life-table
The paired Student t-test was used for comparison ofmethod. Primary patency was considered to begin on
patency rates and intervals. A P value of 0.05 was usedthe day of declotting and to end on the day of access
to determine statistical significance.failure or further reintervention (radiological or surgi-
cal). Secondary patency included all further radiological
therapy (dilation, stent placement, new percutaneous de- RESULTS
clotting) but ended with surgical revision. Death and The mean age was 63.0 6 2.2 (SE) years in the forearm
renal transplantation with a patent fistula were consid- group compared with 70.9 6 3.1 years in the upper arm
ered to be the end of follow-up. group (P 5 0.09). There were 11% of diabetics in the
The interval between interventions was defined as the forearm group and 19% in the upper arm group (P 5
duration of patency between two radiological interven- NS). The mean age of forearm fistulae was 40.6 6 6.5
tions performed to maintain or to restore patency. The months compared with 18.7 6 6.6 months for upper arm
mean intervals between interventions were calculated fistulae (P 5 0.09). There was a small number of women
as follows: The follow-up time after the first successful in the forearm group (36%) but a greater number in the
declotting until the last reintervention was divided by upper arm (53%, P 5 NS).
the number of radiological reinterventions performed. All but two fistulae were treated within three days of
For patients with more than six months of follow-up the onset of thrombosis.
without reintervention, the current follow-up period (at One possibly infected forearm fistula was declotted
after one week of successful antistaphylococcal treat-patient’s death, renal transplantation, or in November
Fig. 4. (A) After retrograde cannulation of this thrombosed forearm cephalic vein (star), it was impossible to traverse the 3 cm long postanastomotic
stenosis (arrowheads) and to find the way back to the artery. Antegrade cannulation of the brachial artery was performed, and a 5F catheter was
pushed selectively into the radial artery (arrow). (B) The 5F catheter (arrowhead) and the hydrophilic guide wire were carefully entered into the
fistula and easily traversed the stenosis.
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Fig. 4. (Continued). (C) Selective catheterization of the introducer sheath placed in the vein was possible with the hydrophilic guide wire pushed
from the brachial artery (thin arrow 5 tip of the sheath entered by the guide wire). The guide wire was pushed as far as possible on contact with
the hemostatic valve of the introducer (wide arrow 5 guidewire rolling back on itself on contact with the hemostatic valve). (D) (bottom of p.
1131) The introducer was then removed. This view shows the guidewire entering the brachial artery through the introducer and exiting the skin
directly from the fistula. (E) The introducer was reintroduced over the guidewire from the fistula to allow passage of the dilation balloon. This
predilation view shows clots on contact with the tight stenosis (arrow) responsible for the thrombosis of the fistula. (F) (opposite page) Final result
after aspiration of clots and dilation of the stenosis to 7 mm. This fistula was still patent at seven months of follow-up.
ment because the patient refused surgery. However, lo- (2 cases). Failures in the upper arm were due in three
cases to long stenoses, which burst after dilation to 5 mmcal inflammation and pain immediately upstream from
the stenosis are frequent in recently thrombosed native and which were not treated by stent placement because
more than 10 cm of stent would have been necessary.fistulae, and the diagnosis of infection is not easy if there
is no fever. In one case, the fragile final arch of an anatomic variation
of the cephalic vein was torn by the regular removal ofOne forearm fistula was declotted two months after
thrombosis in a patient with acute renal transplant fail- the guide wire, and it could not then be recanalized.
The duration of the procedure from initial punctureure. It was feasible because it was a thin vein with a long
stenosis and a very small thrombus. This small but very to completion of compression was recorded from 1995:
134 6 7 minutes in the forearm and 119 6 12 minutescompact, old thrombus migrated into the outflow during
the aspiration attempt, fortunately with no clinical conse- in the upper arm (P 5 0.4).
Including initial failures, primary patency rates in thequence.
The success rate was 93 6 3% (52 out of 56) in the forearm and in the upper arm were 89 6 4% (N 5 46)
and 64 6 12% (N 5 10) at one month, respectively, 89 6forearm and 76 6 10% (13 out of 17) in the upper arm.
Failures in the forearm were due to the impossibility of 5% (N 5 41) and 36 6 14% (N 5 4) at three months,
70 6 8% (N 5 25) and 18 6 12% (N 5 2) at six months,traversing the anastomosis (2 cases) or of recanalizing
the chronic occlusion of the venous outflow at the elbow 49 6 9% (N 5 15), and 9 6 9% (N 5 1) at one year
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(P 5 NS). They were placed during the initial declotting
procedure in 5% of forearm fistulae (1 “Wallstent,” 2
“Passager”) and in 12% of upper arm fistulae (2 “Wall-
stent,” P 5 NS). A total of 8 stents (3 “Wallstent,” 2
“Craggstent,” 3 “Passager”) was used in the 6 forearm
fistulae and 11 stents (9 “Wallstent,” 2 “Passager”) in
the seven upper arm fistulae. The indications for stent
placement were acute rupture (5 out of 19), stenosis
recoil (6 out of 19), and early (,6 months) recurring
stenosis (8 out of 19).
By comparison, 78 prosthetic grafts were declotted
during the same period. The mean patient age was 64
years, and 18% were diabetics. The success rate was
100%. The primary and secondary patency rates at one
year were 14 and 83%, respectively. The mean procedure
time was 119 minutes. The mean interval between inter-
ventions was 6.4 months, and stents were used in 45%
of cases.
Significant complications included one symptomatic
pulmonary embolism during the declotting of a forearm
fistula. The clinical signs started during the urokinase
infusion stage of the “lyse and wait” technique, which
we used at the beginning of our experience. However,
the patient had concomitant lower limb deep venous
thrombosis (DVT). In addition, both DVT and pulmo-
nary embolism recurred spontaneously two years later,
whereas the fistula was patent. It is therefore debatable
whether the first episode of pulmonary embolism was a
complication of the procedure of fistula declotting. One
Fig. 4. (Continued). subacute pseudoaneurysm required surgery within the
week following the declotting of an upper arm fistula:
this occurred early in our experience, and this type of
complication never occurred again because a small sub-(Fig. 8). The rates then declined very slowly and were
cutaneous tunnel was then systematically created be-still 45 6 14% (N 5 6) in the forearm at four years.
Twenty-five additional procedures (20 simple redila- tween the skin and the venous wall. One previously ane-
tions, 5 stent placements, 8 new declottings) were per- mic patient required a blood transfusion. These were the
formed in the forearm during follow-up, in addition to only significant complications, and they accounted for
the 56 initial declottings and 36 additional procedures 3% (3 out of 94) of the procedures.
(13 simple redilations, 9 stent placements, 12 new declot- A small prospective study comprising 21 patients
tings) that were performed in the 17 fistulae in the upper showed an average fall of 1.51 6 0.20 g/dL (range 0.3
arm. to 3.0) in the patients’ hemoglobin rate after aspiration
Secondary patency rates in the forearm and in the upper [13]. During the same interval, a mean fall of 1.33 6
arm were 89 6 5% (N 5 41) and 76 6 12% (N 5 10)
0.16 g/dL was found in patients whose patent fistula was
at three months, respectively, 84 6 6% (N 5 28) and
simply dilated.68 6 14% (N 5 8) at six months, and 81 6 8% (N 5
One patient died during the first month’s follow-up,21) and 50 6 16% (N 5 5) at one year (Fig. 9). The
but death was not related to the declotting procedure.rates declined then very slowly and were still 76 6 14%
Transient arterial emboli occurred in five cases (5%),(N 5 7) in the forearm at four years.
but as for percutaneous transluminal angioplasty (PTA)-The mean interval between interventions was 19.6
induced ruptures and stenosis recoil, they can be consid-months in the forearm compared with 5.7 months in the
ered to be regular procedural difficulties because all wereupper arm (P 5 0.047).
immediately and successfully resolved by thromboaspir-Stents were used in 41% (7 out of 17) of upper arm
fistulae and in only 11% (6 out of 56) of forearm fistulae ation.
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Fig. 5. (A) Thrombosis of this radiocephalic fistula was due to three stenoses, one postanastomotic and two midforearm (arrowheads). (B) Careful
local injection at the anastomosis showed thrombi in the final segment of the feeding artery. It was impossible to aspirate these clots from the
fistula because of the sharp angulation of the anastomosis, and attempts to dislodge or crush with balloons were unsuccessful. (C) After placement
of a safety guide wire from the fistula, aspiration was performed successfully with a 6F catheter (arrow) after antegrade puncture of the brachial
artery at the elbow and selective catheterization of the radial artery. (D) Final result after aspiration of thrombi and dilation of the stenoses to 7
mm. It was not clear whether the residual arterial narrowing just above the anastomosis was a spasm or a stenosis. This fistula was still working
at five months of follow-up.
DISCUSSION abandoned because this technique had many drawbacks:
incorrect placement of the needles with oozing of uroki-Radiological techniques
nase into adjacent tissues, local pain, bleeding due toTo declot a native fistula requires greater technical
reopening of recent dialysis puncture sites, and inconsis-skill and experience than for grafts in the initial cannula-
tent effectiveness. The frequency of significant residualtion and catheterization of the tight underlying stenosis.
clots did not warrant the cost of urokinase and the wasteThe technique of thrombus removal or lysis must, further-
of time.more, be adapted to large vessels and large clots. The
It is obvious that some more expensive mechanicalvolume of thrombus in a native fistula can be high, and
devices available on the market might work, such as theit cannot be systematically decided to push it into the
Hydrolyzert (Cordis, Miami, FL, USA), as reported bylungs, as was reported for grafts using either the pulse-
other researchers [7, 12, 15], although their effectivenessspray method [9] or a Fogarty balloon [6, 14]. Fatal compli-
is questionable in large veins. However, according to thesecations were reported even after small emboli [22, 23].
series, residual clots are almost inevitable after using theThe first teams to report the feasibility of percutaneous
device, and the way they are then treated is questionable.declotting of native fistulae used urokinase infusion for
Vorwerk, Guenther, and Schuermann simply crushedsome hours before dilation or aspiration of residual clots
[4, 17]. This was also our first approach, but it was rapidly them with a balloon, which meant detachment and pul-
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Fig. 5. (Continued).
monary embolization [7], whereas Rousseau et al used and a patient selection bias is possible. The other rates
reported in the literature are not statistically reliablemanual catheter-directed thromboaspiration [15], as we
did. Vorwerk, Guenther, and Schuermann reported that because of the small series.
Although the success rate in the declotting of forearmthey were eventually obliged to trap fresh residual clots
left by the Hydrolyzer with stents, which is an expensive fistulae was inferior to that of grafts, rethrombosis and
the need for prophylactic redilations or stents were, how-method [24].
ever, clearly less frequent than for grafts in our experi-
Results of radiological approach ence, as underlined by the higher primary patency rates
(49 vs. 14% at 1 year). Although secondary patency ratesOur study indicates that the declotting of forearm na-
tive fistulae is more difficult than declotting grafts be- after declotting are similar for forearm native fistulae
and grafts (81 and 83% at 1 year, respectively, in ourcause the immediate success rate is slightly lower (93 vs.
100% in our experience). As in our experience, Over- series), the greater interval between maintenance rein-
terventions in forearm veins (19.6 months vs. 6.4 months,bosch et al reported a 100%, and thus better, success
rate with grafts. Success rates in the recent literature for P , 0.05) confirms that whereas declotting a native fore-
arm fistula is more difficult than declotting a graft, theforearm fistulae range from 63 to 83% according to the
criteria used to define success [7, 12–13, 15, 18]. Our 93% results are more durable and the need for reinterventions
is three times less that of grafts. The results after inter-success rate might be explained by the greater number of
cases and the consequently better completion of our ventional radiology are similar to those after surgery.
As summarized in Mehta’s meta-analysis [2], the initiallearning curve, but it might also be due to the value of
the technique of thromboaspiration. Nevertheless, our failure rate in access creation is higher in native fistulae
than in grafts, and secondary patency rates are similar forresults reflect that a single radiological center experience
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Fig. 6. (A) During the declotting of this thigh fistula, it was impossible to aspirate or even to break up old, hard thrombi in this aneurysm of a
former dialysis site. This “plug” (arrow) of old thrombi caused major narrowing and blocked the flow intermittently. (B) The problem was solved
by placement of a wide-strut stent, which trapped the clots in the aneurysm while reopening a safe lumen (arrow 5 former aneurysm). This fistula
rethrombosed 16 months later and was again successfully declotted percutaneously.
up to three years, but the complications and subsequent it might also be explained by the differences between
the two groups of patients (older patients, higher propor-revisions are three to four times less frequent.
This radiological experience confirms that a forearm tion of diabetics, more recently created fistulae in the
upper arm group). It is even more regrettable that inter-fistula is the access of choice and is not created often
enough in the United States because, as emphasized by ventional radiology works less well in the upper arm, as
it is also in this location that surgical alternatives are theHodges et al, “objective measures such as patency rate
or adequacy of dialysis have less influence on the choice of most limited and vein consuming.
access than physician preference and geographic bias” [25].
Hemoglobin lossOn the other hand, the results in upper arm fistulae
are clearly poorer than in the forearm and are similar Concerns have been raised about the potential blood
loss induced by the thromboaspiration technique. Theto those reported with grafts, with a poor primary pat-
ency rate at one year (9%) and the need for reinterven- results from our prospective study comprising 21 consec-
utive cases of graft and fistula declotting showed an addi-tion every six months. This difference in outcome be-
tween upper arm and forearm fistulae has not been tional negligible average hemoglobin loss of 0.20 g/dL
when compared with 31 patients who underwent dilationreported to date to our knowledge. The difference is
mainly due to the problems encountered in the manage- of their failing but patent accesses [13]. No declotting
technique to date has ever been proved not to inducement of stenoses of the final arch of the cephalic vein
(ruptures or resistance to dilation, early recurrence), but any blood loss, but the success rate achieved should
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Fig. 7. (A) Thrombosis of this transposed brachiobasilic fistula extended up to the subclavian vein. (B) (following page) The attempt to reach
the superior vena cava was unsuccessful because of an old chronic occlusion (arrow) compensated for by a fairly large mediastinal collateral
(arrowheads) with delayed opacification of the innominate vein and vena cava. (C) (following page) Manual catheter-directed thromboaspiration
was easy and very productive despite the great volume of thrombi, giving this a clean, final result. The chronic occlusion of the right brachiocephalic
vein was not recanalized since it was not the cause of the thrombosis of the fistula. (D) (following page) The stenosis responsible for fistula
occlusion was located on the basilic vein just above the anastomosis (arrow) and responded very well to dilation. Systematic angiogram at 18
months showed no restenosis, and this fistula was still working perfectly, with no arm edema, at two years of follow-up.
be weighed against any occasionally higher blood loss and it was replaced by a graft, thus providing a 35%
initial failure rate.induced by a given technique.
Apart from its results, the radiological approach has
Respective values of surgery and radiology several advantages over surgery, including imaging of
the whole fistula from the artery to the superior venaThe majority of surgical results cannot be compared
cava, which minimizes the risk of overlooking associatedwith radiological data because patency in surgical series
lesions, better preservation of the patient’s venous capi-begins at the time the access is inserted and not at the
tal (essential in young patients), less invasiveness (whichtime the access is revised. This is the case for Yasuhara,
is appreciated by patients), and immediate availabilityShigematsu, and Muto, who reported primary patency
of the declotted fistula for dialysis, which is not the caserates of 72, 63 and 41% at one, two, and five years,
when surgical revision results in edema or graft place-respectively, after fistula creation and fabulous 94, 92,
ment.and 89% secondary patency rates at the same intervals
[26]. Unfortunately, they did not provide rates starting
Conclusionfrom fistula revision.
Only one recent article has reported clear secondary This study shows that interventional radiology is a
valid alternative to surgery for the treatment of throm-patency rates after surgical revision of thrombosed fore-
arm native fistulae, with a relatively poor rate of 50% bosed native fistulae for hemodialysis. There is, however,
a learning curve, and not all declotting techniques usedat four months [25]. Another recent article reported the
results of surgical revision; however, the data are difficult for grafts can be used for native fistulae. In view of the
advantages of the percutaneous approach, our opinionto analyze because failing, but still patent fistulae were
mixed with thrombosed fistulae [27]. In 10 out of 29 is that percutaneous radiological treatment should be
attempted first and should be initiated in all dialysiscases, the authors judged the fistula “unsalvageable,”
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Fig. 7. (Continued).
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Fig. 8. Primary patency rates after declotting showing better
results for forearm fistulae (m) compared with upper arm
fistulae (j).
Fig. 9. Secondary patency rates after declot-
ting showing better results for forearm fistulae
(m) compared with upper arm fistulae (j).
and failed hemodialysis access sites: Comparison with surgicalcenters, as long as the local radiologists (or any physician
treatment. Prog Cardiovasc Dis 34:263–278, 1993
performing percutaneous techniques) are trained and 4. Poulain F, Raynaud A, Bourquelot P, Knight C, Rovani X,
motivated. Gaux J: Local thrombolysis and thromboaspiration in the treat-
ment of acutely thrombosed arteriovenous hemodialysis fistulas.
Cardiovasc Intervent Radiol 14:98–101, 1991
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